Pharmafile Logo

Gower Publishing

- PMLiVE

The heavy toll of COVID-19 on cancer patients

We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Blue Latitude Health

- PMLiVE

Unpacking rare diseases in the first edition of Delta magazine

Fishawack Health launches Delta magazine with a deep dive into rare disease commercialization

Blue Latitude Health

Virtual HealthTech conference powered by Impetus Digital: A Customer Story

In this customer story, we summarize one of the pilot projects conducted using our new and award-winning platform: InSite Event™.

Impetus Digital

- PMLiVE

FDA priority review for Roche’s Esbriet in unclassifiable interstitial lung disease

Agency is due to make a decision for the approval by May 2021

- PMLiVE

Janet Woodcock named acting commissioner of the FDA

President Biden is set to formally nominate a commissioner soon

- PMLiVE

Lilly’s antibody bamlanivimab cuts COVID-19 risk by up to 80%

Bamlanivimab-treated care home residents and staff had a significant reduction in COVID-19 risk

- PMLiVE

Gilead’s Jyseleca is given a NICE recommendation for rheumatoid arthritis

JAK inhibitor approved for use in moderate-to-severe RA

- PMLiVE

In plain sight

I usually wouldn’t care about pop culture awards – this time is different

Future-Proofing Healthcare and Medicine

Bogi Eliasen, Director of Health at Copenhagen Institute for Futures Studies, discusses the future of genomics, personalized health, healthcare data, digital health, and more.

Impetus Digital

AI in Computer Vision Technology and the Impact on Healthcare

Moshe Safran, CEO at RSIP Vision USA, delves into a range of topics around computer vision, AI, and deep learning in medical imaging, surgery, and healthcare, including the work that...

Impetus Digital

- PMLiVE

Pfizer/BioNTech’s COVID-19 vaccine found to be effective against UK virus variant

BioNTech is planning to publish analysis on vaccine's efficacy against South African variant

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links